nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—PTGS1—kidney cancer	0.347	1	CbGaD
Sulfamethoxazole—UGT1A9—Sorafenib—kidney cancer	0.0773	0.205	CbGbCtD
Sulfamethoxazole—CYP3A4—Everolimus—kidney cancer	0.0365	0.097	CbGbCtD
Sulfamethoxazole—CYP2C8—Pazopanib—kidney cancer	0.0319	0.0849	CbGbCtD
Sulfamethoxazole—ALB—Erlotinib—kidney cancer	0.0295	0.0784	CbGbCtD
Sulfamethoxazole—CYP3A4—Temsirolimus—kidney cancer	0.0247	0.0655	CbGbCtD
Sulfamethoxazole—CYP2C9—Capecitabine—kidney cancer	0.0232	0.0617	CbGbCtD
Sulfamethoxazole—CYP2C8—Erlotinib—kidney cancer	0.0228	0.0606	CbGbCtD
Sulfamethoxazole—CYP2C8—Paclitaxel—kidney cancer	0.0209	0.0554	CbGbCtD
Sulfamethoxazole—NAT2—urine—kidney cancer	0.0188	0.404	CbGeAlD
Sulfamethoxazole—CYP2C8—Sorafenib—kidney cancer	0.0185	0.0492	CbGbCtD
Sulfamethoxazole—CYP2C9—Paclitaxel—kidney cancer	0.0145	0.0387	CbGbCtD
Sulfamethoxazole—CYP3A4—Pazopanib—kidney cancer	0.013	0.0344	CbGbCtD
Sulfamethoxazole—CYP2C9—Sorafenib—kidney cancer	0.0129	0.0343	CbGbCtD
Sulfamethoxazole—CYP3A4—Erlotinib—kidney cancer	0.00924	0.0246	CbGbCtD
Sulfamethoxazole—CYP3A4—Paclitaxel—kidney cancer	0.00846	0.0225	CbGbCtD
Sulfamethoxazole—CYP3A4—Sorafenib—kidney cancer	0.00751	0.02	CbGbCtD
Sulfamethoxazole—CYP3A4—Vinblastine—kidney cancer	0.00742	0.0197	CbGbCtD
Sulfamethoxazole—CYP3A4—Vincristine—kidney cancer	0.0073	0.0194	CbGbCtD
Sulfamethoxazole—CYP3A4—Sunitinib—kidney cancer	0.00609	0.0162	CbGbCtD
Sulfamethoxazole—NAT1—nephron tubule—kidney cancer	0.0046	0.099	CbGeAlD
Sulfamethoxazole—NAT2—renal system—kidney cancer	0.0046	0.0989	CbGeAlD
Sulfamethoxazole—CYP3A4—Doxorubicin—kidney cancer	0.00456	0.0121	CbGbCtD
Sulfamethoxazole—NAT1—cortex of kidney—kidney cancer	0.00394	0.0847	CbGeAlD
Sulfamethoxazole—CYP2C9—urine—kidney cancer	0.00292	0.0629	CbGeAlD
Sulfamethoxazole—UGT1A9—renal system—kidney cancer	0.00248	0.0534	CbGeAlD
Sulfamethoxazole—UGT1A9—kidney—kidney cancer	0.0024	0.0516	CbGeAlD
Sulfamethoxazole—CYP3A4—urine—kidney cancer	0.00223	0.0479	CbGeAlD
Sulfamethoxazole—CYP2C8—renal system—kidney cancer	0.000805	0.0173	CbGeAlD
Sulfamethoxazole—CYP2C8—kidney—kidney cancer	0.000778	0.0167	CbGeAlD
Sulfamethoxazole—PTGS1—renal system—kidney cancer	0.000653	0.014	CbGeAlD
Sulfamethoxazole—PTGS1—kidney—kidney cancer	0.000631	0.0136	CbGeAlD
Sulfamethoxazole—PTGS1—cardiac atrium—kidney cancer	0.000585	0.0126	CbGeAlD
Sulfamethoxazole—CYP3A4—renal system—kidney cancer	0.000545	0.0117	CbGeAlD
Sulfamethoxazole—CYP3A4—kidney—kidney cancer	0.000527	0.0113	CbGeAlD
Sulfamethoxazole—Sulfanilamide—CA9—kidney cancer	0.000439	0.386	CrCbGaD
Sulfamethoxazole—Sulfanilamide—CA2—kidney cancer	0.000394	0.347	CrCbGaD
Sulfamethoxazole—Dapsone—PTGS1—kidney cancer	0.000193	0.17	CrCbGaD
Sulfamethoxazole—Asthenia—Erlotinib—kidney cancer	0.000155	0.000904	CcSEcCtD
Sulfamethoxazole—Mental disorder—Paclitaxel—kidney cancer	0.000155	0.000904	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Vincristine—kidney cancer	0.000155	0.000904	CcSEcCtD
Sulfamethoxazole—Urticaria—Sorafenib—kidney cancer	0.000154	0.000901	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Doxorubicin—kidney cancer	0.000154	0.000899	CcSEcCtD
Sulfamethoxazole—Malnutrition—Paclitaxel—kidney cancer	0.000154	0.000898	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Dactinomycin—kidney cancer	0.000154	0.000898	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vinblastine—kidney cancer	0.000153	0.000897	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Sorafenib—kidney cancer	0.000153	0.000897	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Sorafenib—kidney cancer	0.000153	0.000897	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Everolimus—kidney cancer	0.000153	0.000894	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Sunitinib—kidney cancer	0.000153	0.000892	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Capecitabine—kidney cancer	0.000153	0.000892	CcSEcCtD
Sulfamethoxazole—Pruritus—Erlotinib—kidney cancer	0.000153	0.000892	CcSEcCtD
Sulfamethoxazole—Fatigue—Dactinomycin—kidney cancer	0.000152	0.000891	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Doxorubicin—kidney cancer	0.000151	0.000882	CcSEcCtD
Sulfamethoxazole—Tension—Paclitaxel—kidney cancer	0.000151	0.000882	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Capecitabine—kidney cancer	0.000151	0.00088	CcSEcCtD
Sulfamethoxazole—Anorexia—Vincristine—kidney cancer	0.00015	0.00088	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Gemcitabine—kidney cancer	0.00015	0.000876	CcSEcCtD
Sulfamethoxazole—Nervousness—Paclitaxel—kidney cancer	0.000149	0.000872	CcSEcCtD
Sulfamethoxazole—Dizziness—Vinblastine—kidney cancer	0.000148	0.000867	CcSEcCtD
Sulfamethoxazole—Dizziness—Everolimus—kidney cancer	0.000148	0.000864	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Sunitinib—kidney cancer	0.000148	0.000863	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Sunitinib—kidney cancer	0.000148	0.000863	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Erlotinib—kidney cancer	0.000147	0.000863	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Gemcitabine—kidney cancer	0.000147	0.000859	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Gemcitabine—kidney cancer	0.000147	0.000857	CcSEcCtD
Sulfamethoxazole—Skin disorder—Gemcitabine—kidney cancer	0.000145	0.000851	CcSEcCtD
Sulfamethoxazole—Hepatitis—Capecitabine—kidney cancer	0.000145	0.000847	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000144	0.000845	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000144	0.000841	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Capecitabine—kidney cancer	0.000143	0.000836	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000143	0.000836	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Sorafenib—kidney cancer	0.000143	0.000836	CcSEcCtD
Sulfamethoxazole—Insomnia—Vincristine—kidney cancer	0.000143	0.000835	CcSEcCtD
Sulfamethoxazole—Anorexia—Gemcitabine—kidney cancer	0.000143	0.000835	CcSEcCtD
Sulfamethoxazole—Vomiting—Vinblastine—kidney cancer	0.000143	0.000834	CcSEcCtD
Sulfamethoxazole—Dizziness—Erlotinib—kidney cancer	0.000143	0.000834	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Capecitabine—kidney cancer	0.000142	0.000832	CcSEcCtD
Sulfamethoxazole—Vomiting—Everolimus—kidney cancer	0.000142	0.000831	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Capecitabine—kidney cancer	0.000142	0.00083	CcSEcCtD
Sulfamethoxazole—Renal impairment—Doxorubicin—kidney cancer	0.000142	0.000829	CcSEcCtD
Sulfamethoxazole—Rash—Everolimus—kidney cancer	0.000141	0.000824	CcSEcCtD
Sulfamethoxazole—Dermatitis—Everolimus—kidney cancer	0.000141	0.000823	CcSEcCtD
Sulfamethoxazole—Headache—Vinblastine—kidney cancer	0.00014	0.000822	CcSEcCtD
Sulfamethoxazole—Angioedema—Paclitaxel—kidney cancer	0.00014	0.000821	CcSEcCtD
Sulfamethoxazole—Purpura—Doxorubicin—kidney cancer	0.00014	0.000819	CcSEcCtD
Sulfamethoxazole—Headache—Everolimus—kidney cancer	0.00014	0.000819	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dactinomycin—kidney cancer	0.00014	0.000817	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dactinomycin—kidney cancer	0.00014	0.000817	CcSEcCtD
Sulfamethoxazole—Asthenia—Sorafenib—kidney cancer	0.000139	0.000814	CcSEcCtD
Sulfamethoxazole—Hypoglycaemia—Doxorubicin—kidney cancer	0.000138	0.000809	CcSEcCtD
Sulfamethoxazole—Vertigo—Paclitaxel—kidney cancer	0.000138	0.000807	CcSEcCtD
Sulfamethoxazole—Leukopenia—Paclitaxel—kidney cancer	0.000137	0.000804	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Sunitinib—kidney cancer	0.000137	0.000804	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Vincristine—kidney cancer	0.000137	0.000802	CcSEcCtD
Sulfamethoxazole—Pruritus—Sorafenib—kidney cancer	0.000137	0.000802	CcSEcCtD
Sulfamethoxazole—Vomiting—Erlotinib—kidney cancer	0.000137	0.000802	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Capecitabine—kidney cancer	0.000137	0.000801	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000136	0.000798	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Vincristine—kidney cancer	0.000136	0.000797	CcSEcCtD
Sulfamethoxazole—Fatigue—Vincristine—kidney cancer	0.000136	0.000796	CcSEcCtD
Sulfamethoxazole—Rash—Erlotinib—kidney cancer	0.000136	0.000795	CcSEcCtD
Sulfamethoxazole—Dermatitis—Erlotinib—kidney cancer	0.000136	0.000794	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Doxorubicin—kidney cancer	0.000135	0.000792	CcSEcCtD
Sulfamethoxazole—Insomnia—Gemcitabine—kidney cancer	0.000135	0.000792	CcSEcCtD
Sulfamethoxazole—Eye disorder—Capecitabine—kidney cancer	0.000135	0.000791	CcSEcCtD
Sulfamethoxazole—Headache—Erlotinib—kidney cancer	0.000135	0.00079	CcSEcCtD
Sulfamethoxazole—Tinnitus—Capecitabine—kidney cancer	0.000135	0.00079	CcSEcCtD
Sulfamethoxazole—Cough—Paclitaxel—kidney cancer	0.000134	0.000784	CcSEcCtD
Sulfamethoxazole—Asthenia—Sunitinib—kidney cancer	0.000134	0.000783	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Gemcitabine—kidney cancer	0.000133	0.000781	CcSEcCtD
Sulfamethoxazole—Nausea—Vinblastine—kidney cancer	0.000133	0.000779	CcSEcCtD
Sulfamethoxazole—Convulsion—Paclitaxel—kidney cancer	0.000133	0.000778	CcSEcCtD
Sulfamethoxazole—Nausea—Everolimus—kidney cancer	0.000133	0.000776	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Sorafenib—kidney cancer	0.000133	0.000776	CcSEcCtD
Sulfamethoxazole—Pruritus—Sunitinib—kidney cancer	0.000132	0.000772	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Capecitabine—kidney cancer	0.000131	0.000765	CcSEcCtD
Sulfamethoxazole—Arthralgia—Paclitaxel—kidney cancer	0.000131	0.000765	CcSEcCtD
Sulfamethoxazole—Myalgia—Paclitaxel—kidney cancer	0.000131	0.000765	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Capecitabine—kidney cancer	0.000131	0.000763	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Gemcitabine—kidney cancer	0.00013	0.000761	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Dactinomycin—kidney cancer	0.00013	0.000761	CcSEcCtD
Sulfamethoxazole—Chills—Capecitabine—kidney cancer	0.00013	0.00076	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00013	0.00076	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000129	0.000756	CcSEcCtD
Sulfamethoxazole—Fatigue—Gemcitabine—kidney cancer	0.000129	0.000755	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Vincristine—kidney cancer	0.000129	0.000755	CcSEcCtD
Sulfamethoxazole—Dizziness—Sorafenib—kidney cancer	0.000128	0.00075	CcSEcCtD
Sulfamethoxazole—Nausea—Erlotinib—kidney cancer	0.000128	0.000749	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Sunitinib—kidney cancer	0.000128	0.000747	CcSEcCtD
Sulfamethoxazole—Ataxia—Doxorubicin—kidney cancer	0.000127	0.000742	CcSEcCtD
Sulfamethoxazole—Mental disorder—Capecitabine—kidney cancer	0.000127	0.000742	CcSEcCtD
Sulfamethoxazole—Asthenia—Dactinomycin—kidney cancer	0.000127	0.000741	CcSEcCtD
Sulfamethoxazole—Malnutrition—Capecitabine—kidney cancer	0.000126	0.000737	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Paclitaxel—kidney cancer	0.000125	0.000733	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Vincristine—kidney cancer	0.000125	0.00073	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Vincristine—kidney cancer	0.000125	0.00073	CcSEcCtD
Sulfamethoxazole—Dizziness—Sunitinib—kidney cancer	0.000123	0.000722	CcSEcCtD
Sulfamethoxazole—Vomiting—Sorafenib—kidney cancer	0.000123	0.000721	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Paclitaxel—kidney cancer	0.000123	0.000719	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Paclitaxel—kidney cancer	0.000123	0.000718	CcSEcCtD
Sulfamethoxazole—Rash—Sorafenib—kidney cancer	0.000122	0.000715	CcSEcCtD
Sulfamethoxazole—Dermatitis—Sorafenib—kidney cancer	0.000122	0.000714	CcSEcCtD
Sulfamethoxazole—Skin disorder—Paclitaxel—kidney cancer	0.000122	0.000712	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000121	0.000711	CcSEcCtD
Sulfamethoxazole—Headache—Sorafenib—kidney cancer	0.000121	0.000711	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dactinomycin—kidney cancer	0.000121	0.000707	CcSEcCtD
Sulfamethoxazole—Anorexia—Paclitaxel—kidney cancer	0.000119	0.000699	CcSEcCtD
Sulfamethoxazole—Vomiting—Sunitinib—kidney cancer	0.000119	0.000694	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Gemcitabine—kidney cancer	0.000118	0.000692	CcSEcCtD
Sulfamethoxazole—Rash—Sunitinib—kidney cancer	0.000118	0.000688	CcSEcCtD
Sulfamethoxazole—Dermatitis—Sunitinib—kidney cancer	0.000118	0.000687	CcSEcCtD
Sulfamethoxazole—Headache—Sunitinib—kidney cancer	0.000117	0.000684	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Vincristine—kidney cancer	0.000116	0.00068	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Doxorubicin—kidney cancer	0.000115	0.000675	CcSEcCtD
Sulfamethoxazole—Nausea—Sorafenib—kidney cancer	0.000115	0.000674	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Doxorubicin—kidney cancer	0.000114	0.000669	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000114	0.000668	CcSEcCtD
Sulfamethoxazole—Insomnia—Paclitaxel—kidney cancer	0.000113	0.000663	CcSEcCtD
Sulfamethoxazole—Vertigo—Capecitabine—kidney cancer	0.000113	0.000662	CcSEcCtD
Sulfamethoxazole—Asthenia—Vincristine—kidney cancer	0.000113	0.000662	CcSEcCtD
Sulfamethoxazole—Leukopenia—Capecitabine—kidney cancer	0.000113	0.00066	CcSEcCtD
Sulfamethoxazole—Vomiting—Dactinomycin—kidney cancer	0.000112	0.000657	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Paclitaxel—kidney cancer	0.000112	0.000654	CcSEcCtD
Sulfamethoxazole—Rash—Dactinomycin—kidney cancer	0.000111	0.000651	CcSEcCtD
Sulfamethoxazole—Nausea—Sunitinib—kidney cancer	0.000111	0.000648	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Doxorubicin—kidney cancer	0.000111	0.000648	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS2—kidney cancer	0.00011	0.0972	CrCbGaD
Sulfamethoxazole—Dyspepsia—Paclitaxel—kidney cancer	0.00011	0.000645	CcSEcCtD
Sulfamethoxazole—Cough—Capecitabine—kidney cancer	0.00011	0.000643	CcSEcCtD
Sulfamethoxazole—Neutropenia—Doxorubicin—kidney cancer	0.000109	0.000638	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Paclitaxel—kidney cancer	0.000109	0.000637	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000108	0.000633	CcSEcCtD
Sulfamethoxazole—Fatigue—Paclitaxel—kidney cancer	0.000108	0.000632	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vincristine—kidney cancer	0.000108	0.000632	CcSEcCtD
Sulfamethoxazole—Asthenia—Gemcitabine—kidney cancer	0.000107	0.000628	CcSEcCtD
Sulfamethoxazole—Arthralgia—Capecitabine—kidney cancer	0.000107	0.000628	CcSEcCtD
Sulfamethoxazole—Myalgia—Capecitabine—kidney cancer	0.000107	0.000628	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000107	0.000623	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000106	0.000623	CcSEcCtD
Sulfamethoxazole—Pruritus—Gemcitabine—kidney cancer	0.000106	0.00062	CcSEcCtD
Sulfamethoxazole—Nausea—Dactinomycin—kidney cancer	0.000105	0.000614	CcSEcCtD
Sulfamethoxazole—Pneumonia—Doxorubicin—kidney cancer	0.000105	0.000612	CcSEcCtD
Sulfamethoxazole—Dizziness—Vincristine—kidney cancer	0.000104	0.00061	CcSEcCtD
Sulfamethoxazole—Infestation—Doxorubicin—kidney cancer	0.000104	0.000608	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Doxorubicin—kidney cancer	0.000104	0.000608	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000103	0.000603	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000103	0.0006	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Gemcitabine—kidney cancer	0.000102	0.000599	CcSEcCtD
Sulfamethoxazole—Renal failure—Doxorubicin—kidney cancer	0.000102	0.000598	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000102	0.000596	CcSEcCtD
Sulfamethoxazole—Stomatitis—Doxorubicin—kidney cancer	0.000101	0.000593	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Capecitabine—kidney cancer	0.000101	0.00059	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Capecitabine—kidney cancer	0.000101	0.000589	CcSEcCtD
Sulfamethoxazole—Vomiting—Vincristine—kidney cancer	0.0001	0.000587	CcSEcCtD
Sulfamethoxazole—Skin disorder—Capecitabine—kidney cancer	9.99e-05	0.000584	CcSEcCtD
Sulfamethoxazole—Urticaria—Paclitaxel—kidney cancer	9.96e-05	0.000582	CcSEcCtD
Sulfamethoxazole—Rash—Vincristine—kidney cancer	9.95e-05	0.000582	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vincristine—kidney cancer	9.94e-05	0.000581	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Paclitaxel—kidney cancer	9.91e-05	0.00058	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Paclitaxel—kidney cancer	9.91e-05	0.00058	CcSEcCtD
Sulfamethoxazole—Headache—Vincristine—kidney cancer	9.89e-05	0.000578	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Doxorubicin—kidney cancer	9.83e-05	0.000575	CcSEcCtD
Sulfamethoxazole—Anorexia—Capecitabine—kidney cancer	9.81e-05	0.000574	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Doxorubicin—kidney cancer	9.7e-05	0.000567	CcSEcCtD
Sulfamethoxazole—Vomiting—Gemcitabine—kidney cancer	9.52e-05	0.000557	CcSEcCtD
Sulfamethoxazole—Rash—Gemcitabine—kidney cancer	9.44e-05	0.000552	CcSEcCtD
Sulfamethoxazole—Dermatitis—Gemcitabine—kidney cancer	9.43e-05	0.000552	CcSEcCtD
Sulfamethoxazole—Headache—Gemcitabine—kidney cancer	9.38e-05	0.000549	CcSEcCtD
Sulfamethoxazole—Nausea—Vincristine—kidney cancer	9.38e-05	0.000548	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Capecitabine—kidney cancer	9.37e-05	0.000548	CcSEcCtD
Sulfamethoxazole—Hepatitis—Doxorubicin—kidney cancer	9.33e-05	0.000546	CcSEcCtD
Sulfamethoxazole—Insomnia—Capecitabine—kidney cancer	9.3e-05	0.000544	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Paclitaxel—kidney cancer	9.24e-05	0.00054	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Doxorubicin—kidney cancer	9.22e-05	0.000539	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Doxorubicin—kidney cancer	9.17e-05	0.000536	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Capecitabine—kidney cancer	9.17e-05	0.000536	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Doxorubicin—kidney cancer	9.15e-05	0.000535	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Capecitabine—kidney cancer	9.06e-05	0.00053	CcSEcCtD
Sulfamethoxazole—Asthenia—Paclitaxel—kidney cancer	8.99e-05	0.000526	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Capecitabine—kidney cancer	8.94e-05	0.000523	CcSEcCtD
Sulfamethoxazole—Nausea—Gemcitabine—kidney cancer	8.89e-05	0.00052	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Capecitabine—kidney cancer	8.88e-05	0.000519	CcSEcCtD
Sulfamethoxazole—Fatigue—Capecitabine—kidney cancer	8.87e-05	0.000519	CcSEcCtD
Sulfamethoxazole—Pruritus—Paclitaxel—kidney cancer	8.87e-05	0.000519	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Doxorubicin—kidney cancer	8.83e-05	0.000516	CcSEcCtD
Sulfamethoxazole—Eye disorder—Doxorubicin—kidney cancer	8.72e-05	0.00051	CcSEcCtD
Sulfamethoxazole—Tinnitus—Doxorubicin—kidney cancer	8.7e-05	0.000509	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Paclitaxel—kidney cancer	8.58e-05	0.000502	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Doxorubicin—kidney cancer	8.43e-05	0.000493	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Capecitabine—kidney cancer	8.41e-05	0.000492	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Doxorubicin—kidney cancer	8.41e-05	0.000492	CcSEcCtD
Sulfamethoxazole—Chills—Doxorubicin—kidney cancer	8.38e-05	0.00049	CcSEcCtD
Sulfamethoxazole—Dizziness—Paclitaxel—kidney cancer	8.29e-05	0.000485	CcSEcCtD
Sulfamethoxazole—Mental disorder—Doxorubicin—kidney cancer	8.18e-05	0.000478	CcSEcCtD
Sulfamethoxazole—Urticaria—Capecitabine—kidney cancer	8.17e-05	0.000478	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Capecitabine—kidney cancer	8.13e-05	0.000476	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Capecitabine—kidney cancer	8.13e-05	0.000476	CcSEcCtD
Sulfamethoxazole—Malnutrition—Doxorubicin—kidney cancer	8.13e-05	0.000475	CcSEcCtD
Sulfamethoxazole—Tension—Doxorubicin—kidney cancer	7.97e-05	0.000466	CcSEcCtD
Sulfamethoxazole—Vomiting—Paclitaxel—kidney cancer	7.97e-05	0.000466	CcSEcCtD
Sulfamethoxazole—Rash—Paclitaxel—kidney cancer	7.9e-05	0.000462	CcSEcCtD
Sulfamethoxazole—Dermatitis—Paclitaxel—kidney cancer	7.9e-05	0.000462	CcSEcCtD
Sulfamethoxazole—Nervousness—Doxorubicin—kidney cancer	7.89e-05	0.000462	CcSEcCtD
Sulfamethoxazole—Headache—Paclitaxel—kidney cancer	7.85e-05	0.000459	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Capecitabine—kidney cancer	7.58e-05	0.000443	CcSEcCtD
Sulfamethoxazole—Nausea—Paclitaxel—kidney cancer	7.45e-05	0.000435	CcSEcCtD
Sulfamethoxazole—Asthenia—Capecitabine—kidney cancer	7.38e-05	0.000432	CcSEcCtD
Sulfamethoxazole—Vertigo—Doxorubicin—kidney cancer	7.3e-05	0.000427	CcSEcCtD
Sulfamethoxazole—Pruritus—Capecitabine—kidney cancer	7.28e-05	0.000426	CcSEcCtD
Sulfamethoxazole—Leukopenia—Doxorubicin—kidney cancer	7.27e-05	0.000425	CcSEcCtD
Sulfamethoxazole—Cough—Doxorubicin—kidney cancer	7.09e-05	0.000415	CcSEcCtD
Sulfamethoxazole—Convulsion—Doxorubicin—kidney cancer	7.04e-05	0.000412	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Capecitabine—kidney cancer	7.04e-05	0.000412	CcSEcCtD
Sulfamethoxazole—Arthralgia—Doxorubicin—kidney cancer	6.92e-05	0.000405	CcSEcCtD
Sulfamethoxazole—Myalgia—Doxorubicin—kidney cancer	6.92e-05	0.000405	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.87e-05	0.000402	CcSEcCtD
Sulfamethoxazole—Dizziness—Capecitabine—kidney cancer	6.8e-05	0.000398	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Doxorubicin—kidney cancer	6.63e-05	0.000388	CcSEcCtD
Sulfamethoxazole—Vomiting—Capecitabine—kidney cancer	6.54e-05	0.000383	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Doxorubicin—kidney cancer	6.5e-05	0.00038	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Doxorubicin—kidney cancer	6.49e-05	0.00038	CcSEcCtD
Sulfamethoxazole—Rash—Capecitabine—kidney cancer	6.49e-05	0.000379	CcSEcCtD
Sulfamethoxazole—Dermatitis—Capecitabine—kidney cancer	6.48e-05	0.000379	CcSEcCtD
Sulfamethoxazole—Headache—Capecitabine—kidney cancer	6.44e-05	0.000377	CcSEcCtD
Sulfamethoxazole—Skin disorder—Doxorubicin—kidney cancer	6.44e-05	0.000377	CcSEcCtD
Sulfamethoxazole—Anorexia—Doxorubicin—kidney cancer	6.32e-05	0.00037	CcSEcCtD
Sulfamethoxazole—Nausea—Capecitabine—kidney cancer	6.11e-05	0.000357	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	6.04e-05	0.000353	CcSEcCtD
Sulfamethoxazole—Insomnia—Doxorubicin—kidney cancer	6e-05	0.000351	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Doxorubicin—kidney cancer	5.91e-05	0.000346	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Doxorubicin—kidney cancer	5.84e-05	0.000341	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Doxorubicin—kidney cancer	5.76e-05	0.000337	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.73e-05	0.000335	CcSEcCtD
Sulfamethoxazole—Fatigue—Doxorubicin—kidney cancer	5.72e-05	0.000334	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Doxorubicin—kidney cancer	5.42e-05	0.000317	CcSEcCtD
Sulfamethoxazole—Urticaria—Doxorubicin—kidney cancer	5.27e-05	0.000308	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Doxorubicin—kidney cancer	5.24e-05	0.000307	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Doxorubicin—kidney cancer	5.24e-05	0.000307	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Doxorubicin—kidney cancer	4.89e-05	0.000286	CcSEcCtD
Sulfamethoxazole—Asthenia—Doxorubicin—kidney cancer	4.76e-05	0.000278	CcSEcCtD
Sulfamethoxazole—Pruritus—Doxorubicin—kidney cancer	4.69e-05	0.000274	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Doxorubicin—kidney cancer	4.54e-05	0.000265	CcSEcCtD
Sulfamethoxazole—Dizziness—Doxorubicin—kidney cancer	4.39e-05	0.000256	CcSEcCtD
Sulfamethoxazole—Vomiting—Doxorubicin—kidney cancer	4.22e-05	0.000247	CcSEcCtD
Sulfamethoxazole—Rash—Doxorubicin—kidney cancer	4.18e-05	0.000245	CcSEcCtD
Sulfamethoxazole—Dermatitis—Doxorubicin—kidney cancer	4.18e-05	0.000244	CcSEcCtD
Sulfamethoxazole—Headache—Doxorubicin—kidney cancer	4.15e-05	0.000243	CcSEcCtD
Sulfamethoxazole—Nausea—Doxorubicin—kidney cancer	3.94e-05	0.00023	CcSEcCtD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.9e-05	0.000504	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.89e-05	0.000502	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PDHB—kidney cancer	2.88e-05	0.000501	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CA9—kidney cancer	2.88e-05	0.0005	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALDH1A1—kidney cancer	2.88e-05	0.0005	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.88e-05	0.000499	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—POMC—kidney cancer	2.87e-05	0.000499	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PDHB—kidney cancer	2.87e-05	0.000498	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.81e-05	0.000488	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ACY1—kidney cancer	2.76e-05	0.000479	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SLC5A3—kidney cancer	2.76e-05	0.000479	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PGK1—kidney cancer	2.76e-05	0.000479	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CCBL1—kidney cancer	2.71e-05	0.000471	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—LDHB—kidney cancer	2.7e-05	0.00047	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CCBL1—kidney cancer	2.7e-05	0.000468	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—POMC—kidney cancer	2.68e-05	0.000466	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.45e-05	0.000426	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CRABP1—kidney cancer	2.45e-05	0.000425	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.44e-05	0.000423	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.38e-05	0.000413	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.35e-05	0.000409	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPAT—kidney cancer	2.35e-05	0.000408	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GLIPR1—kidney cancer	2.35e-05	0.000408	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PDHB—kidney cancer	2.35e-05	0.000408	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CA9—kidney cancer	2.34e-05	0.000407	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.34e-05	0.000407	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—POMC—kidney cancer	2.34e-05	0.000406	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GLIPR1—kidney cancer	2.34e-05	0.000406	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPAT—kidney cancer	2.34e-05	0.000406	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.32e-05	0.000403	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.31e-05	0.000401	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.3e-05	0.000399	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.29e-05	0.000398	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.28e-05	0.000397	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ITPR2—kidney cancer	2.27e-05	0.000395	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CCBL1—kidney cancer	2.21e-05	0.000383	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—APRT—kidney cancer	2.18e-05	0.00038	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—FH—kidney cancer	2.18e-05	0.00038	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.18e-05	0.000379	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—APRT—kidney cancer	2.17e-05	0.000377	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—FH—kidney cancer	2.17e-05	0.000377	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IFNA1—kidney cancer	2.15e-05	0.000374	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.15e-05	0.000374	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTGS2—kidney cancer	2.14e-05	0.000372	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.14e-05	0.000371	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.12e-05	0.000369	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.1e-05	0.000364	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ACHE—kidney cancer	2.07e-05	0.00036	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTT1—kidney cancer	2.07e-05	0.00036	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.07e-05	0.000359	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPC3—kidney cancer	2.05e-05	0.000357	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPC3—kidney cancer	2.04e-05	0.000355	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.04e-05	0.000354	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IFNA2—kidney cancer	2.01e-05	0.000348	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CA2—kidney cancer	2e-05	0.000347	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2e-05	0.000347	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.99e-05	0.000346	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CRABP1—kidney cancer	1.99e-05	0.000346	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CA2—kidney cancer	1.99e-05	0.000345	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SCARB1—kidney cancer	1.96e-05	0.000341	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALAD—kidney cancer	1.95e-05	0.000338	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS1—kidney cancer	1.94e-05	0.000338	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ALAD—kidney cancer	1.94e-05	0.000336	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—RAF1—kidney cancer	1.93e-05	0.000335	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.93e-05	0.000335	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPAT—kidney cancer	1.91e-05	0.000332	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.91e-05	0.000332	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PSMD7—kidney cancer	1.91e-05	0.000331	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.9e-05	0.00033	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ST3GAL2—kidney cancer	1.89e-05	0.000328	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.89e-05	0.000328	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.87e-05	0.000325	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTEN—kidney cancer	1.87e-05	0.000324	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.86e-05	0.000323	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ITPR2—kidney cancer	1.85e-05	0.000322	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ALDH1A1—kidney cancer	1.85e-05	0.000321	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ACY1—kidney cancer	1.82e-05	0.000316	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—BCHE—kidney cancer	1.81e-05	0.000314	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IGF2—kidney cancer	1.81e-05	0.000314	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SLC5A5—kidney cancer	1.78e-05	0.00031	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PGK1—kidney cancer	1.78e-05	0.000309	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.78e-05	0.000309	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—APRT—kidney cancer	1.78e-05	0.000309	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—FH—kidney cancer	1.78e-05	0.000309	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PGK1—kidney cancer	1.77e-05	0.000308	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC5A3—kidney cancer	1.77e-05	0.000308	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—LDHB—kidney cancer	1.75e-05	0.000303	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.74e-05	0.000302	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LDHB—kidney cancer	1.74e-05	0.000302	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	1.73e-05	0.0003	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SLC2A1—kidney cancer	1.72e-05	0.000299	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.71e-05	0.000297	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ACHE—kidney cancer	1.69e-05	0.000294	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTT1—kidney cancer	1.69e-05	0.000294	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPC3—kidney cancer	1.67e-05	0.00029	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.67e-05	0.00029	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CA2—kidney cancer	1.63e-05	0.000283	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SCARB1—kidney cancer	1.6e-05	0.000278	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALAD—kidney cancer	1.58e-05	0.000275	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PSMD7—kidney cancer	1.55e-05	0.00027	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PDHB—kidney cancer	1.55e-05	0.000269	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.55e-05	0.000269	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—POMC—kidney cancer	1.54e-05	0.000268	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.52e-05	0.000264	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CA9—kidney cancer	1.51e-05	0.000263	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.51e-05	0.000263	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CA9—kidney cancer	1.51e-05	0.000262	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.48e-05	0.000257	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—BCHE—kidney cancer	1.47e-05	0.000256	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.47e-05	0.000256	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	1.47e-05	0.000255	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.46e-05	0.000253	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CCBL1—kidney cancer	1.45e-05	0.000253	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SLC5A5—kidney cancer	1.45e-05	0.000253	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.45e-05	0.000252	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PGK1—kidney cancer	1.45e-05	0.000252	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTP1—kidney cancer	1.44e-05	0.00025	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LDHB—kidney cancer	1.42e-05	0.000247	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SLC2A1—kidney cancer	1.4e-05	0.000244	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	1.39e-05	0.000241	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.36e-05	0.000237	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ABCB1—kidney cancer	1.36e-05	0.000236	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	1.32e-05	0.00023	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GSTM1—kidney cancer	1.32e-05	0.000229	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CA—kidney cancer	1.32e-05	0.000229	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CRABP1—kidney cancer	1.29e-05	0.000224	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CRABP1—kidney cancer	1.28e-05	0.000222	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPAT—kidney cancer	1.26e-05	0.000219	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.26e-05	0.000219	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP1A1—kidney cancer	1.25e-05	0.000217	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CA9—kidney cancer	1.23e-05	0.000214	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.2e-05	0.000209	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ITPR2—kidney cancer	1.2e-05	0.000208	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ITPR2—kidney cancer	1.19e-05	0.000207	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.19e-05	0.000206	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—FH—kidney cancer	1.17e-05	0.000204	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—APRT—kidney cancer	1.17e-05	0.000204	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTP1—kidney cancer	1.17e-05	0.000204	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	1.15e-05	0.000199	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ABCB1—kidney cancer	1.11e-05	0.000193	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.1e-05	0.000192	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPC3—kidney cancer	1.1e-05	0.000192	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.1e-05	0.000191	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTT1—kidney cancer	1.09e-05	0.00019	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ACHE—kidney cancer	1.09e-05	0.00019	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTT1—kidney cancer	1.09e-05	0.000189	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ACHE—kidney cancer	1.09e-05	0.000189	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GSTM1—kidney cancer	1.08e-05	0.000187	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CA2—kidney cancer	1.07e-05	0.000186	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CRABP1—kidney cancer	1.05e-05	0.000182	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALAD—kidney cancer	1.05e-05	0.000182	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SCARB1—kidney cancer	1.03e-05	0.00018	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.03e-05	0.000179	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SCARB1—kidney cancer	1.03e-05	0.000179	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS1—kidney cancer	1.02e-05	0.000178	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP1A1—kidney cancer	1.02e-05	0.000177	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.02e-05	0.000177	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS1—kidney cancer	1.02e-05	0.000177	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PSMD7—kidney cancer	1e-05	0.000174	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PSMD7—kidney cancer	9.98e-06	0.000173	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALDH1A1—kidney cancer	9.97e-06	0.000173	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—RAF1—kidney cancer	9.94e-06	0.000173	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ITPR2—kidney cancer	9.74e-06	0.000169	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PGK1—kidney cancer	9.56e-06	0.000166	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC5A3—kidney cancer	9.56e-06	0.000166	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—BCHE—kidney cancer	9.51e-06	0.000165	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—BCHE—kidney cancer	9.46e-06	0.000164	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC5A5—kidney cancer	9.39e-06	0.000163	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LDHB—kidney cancer	9.38e-06	0.000163	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC5A5—kidney cancer	9.34e-06	0.000162	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—POMC—kidney cancer	9.33e-06	0.000162	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC2A1—kidney cancer	9.07e-06	0.000158	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC2A1—kidney cancer	9.02e-06	0.000157	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.98e-06	0.000156	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—kidney cancer	8.91e-06	0.000155	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTT1—kidney cancer	8.88e-06	0.000154	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ACHE—kidney cancer	8.88e-06	0.000154	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.8e-06	0.000153	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.75e-06	0.000152	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	8.6e-06	0.000149	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SCARB1—kidney cancer	8.41e-06	0.000146	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.38e-06	0.000146	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS1—kidney cancer	8.33e-06	0.000145	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PSMD7—kidney cancer	8.16e-06	0.000142	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CA9—kidney cancer	8.13e-06	0.000141	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—BCHE—kidney cancer	7.74e-06	0.000134	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.68e-06	0.000133	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC5A5—kidney cancer	7.65e-06	0.000133	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.63e-06	0.000133	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—POMC—kidney cancer	7.61e-06	0.000132	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—kidney cancer	7.57e-06	0.000132	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTP1—kidney cancer	7.57e-06	0.000131	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTP1—kidney cancer	7.52e-06	0.000131	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—kidney cancer	7.44e-06	0.000129	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC2A1—kidney cancer	7.38e-06	0.000128	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.16e-06	0.000124	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK3—kidney cancer	7.16e-06	0.000124	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCB1—kidney cancer	7.16e-06	0.000124	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCB1—kidney cancer	7.12e-06	0.000124	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GSTM1—kidney cancer	6.95e-06	0.000121	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GSTM1—kidney cancer	6.91e-06	0.00012	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CRABP1—kidney cancer	6.91e-06	0.00012	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK1—kidney cancer	6.82e-06	0.000118	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1A1—kidney cancer	6.59e-06	0.000115	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1A1—kidney cancer	6.55e-06	0.000114	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTEN—kidney cancer	6.49e-06	0.000113	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KRAS—kidney cancer	6.44e-06	0.000112	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ITPR2—kidney cancer	6.43e-06	0.000112	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.25e-06	0.000109	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTP1—kidney cancer	6.16e-06	0.000107	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—kidney cancer	6.07e-06	0.000105	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—kidney cancer	5.91e-06	0.000103	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ACHE—kidney cancer	5.86e-06	0.000102	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTT1—kidney cancer	5.86e-06	0.000102	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCB1—kidney cancer	5.83e-06	0.000101	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—kidney cancer	5.72e-06	9.94e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GSTM1—kidney cancer	5.66e-06	9.83e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SCARB1—kidney cancer	5.55e-06	9.64e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS1—kidney cancer	5.49e-06	9.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.42e-06	9.41e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.38e-06	9.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PSMD7—kidney cancer	5.38e-06	9.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1A1—kidney cancer	5.37e-06	9.32e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTEN—kidney cancer	5.29e-06	9.19e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BCHE—kidney cancer	5.1e-06	8.87e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.04e-06	8.76e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—POMC—kidney cancer	4.91e-06	8.54e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—POMC—kidney cancer	4.89e-06	8.49e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.87e-06	8.46e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—kidney cancer	4.58e-06	7.96e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.41e-06	7.66e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTP1—kidney cancer	4.06e-06	7.06e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—POMC—kidney cancer	4e-06	6.95e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—kidney cancer	3.92e-06	6.81e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—kidney cancer	3.9e-06	6.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCB1—kidney cancer	3.84e-06	6.68e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—kidney cancer	3.73e-06	6.49e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GSTM1—kidney cancer	3.73e-06	6.48e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.54e-06	6.15e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTEN—kidney cancer	3.42e-06	5.94e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTEN—kidney cancer	3.4e-06	5.91e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—kidney cancer	3.19e-06	5.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTEN—kidney cancer	2.78e-06	4.83e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—POMC—kidney cancer	2.64e-06	4.58e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.41e-06	4.19e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—kidney cancer	2.4e-06	4.17e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—kidney cancer	2.1e-06	3.66e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.96e-06	3.41e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTEN—kidney cancer	1.84e-06	3.19e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.29e-06	2.25e-05	CbGpPWpGaD
